We are live on ! Find out more
OC

Oakworth Capital Portfolio holdings

AUM $2.1B
1-Year Est. Return 24.07%
This Fund
S&P 500
This Quarter Est. Return
-0.25%
1 Year Est. Return
+24.07%
3 Year Est. Return
+64.28%
5 Year Est. Return
+64.42%
10 Year Est. Return
+240.11%
AUM
$1.45B
AUM Growth
+$11M
Cap. Flow
+$24.8M
Cap. Flow %
1.71%
Top 10 Hldgs %
61.57%
Holding
694
New
26
Increased
100
Reduced
172
Closed
65

Top Buys

Rank Stock Value
1
BND icon
Vanguard Total Bond Market
BND
+$5.57M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$3.38M
3
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$2.96M
4
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$2.77M
5
VGIT icon
Vanguard Intermediate-Term Treasury ETF
VGIT
+$1.96M

Top Sells

Rank Stock Value
1
RF icon
Regions Financial
RF
+$3.18M
2
SO icon
Southern Company
SO
+$1.49M
3
PFE icon
Pfizer
PFE
+$988K
4
MUB icon
iShares National Muni Bond ETF
MUB
+$769K
5
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$691K

Sector Composition

Rank Sector Weight
1 Technology 7.05%
2 Financials 6.18%
3 Industrials 4.37%
4 Consumer Staples 3.57%
5 Communication Services 2.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FAST icon
326
Fastenal
FAST
$55.5B
$74K 0.01%
2,058
-48
-2% -$1.87K
URI icon
327
United Rentals
URI
$70.4B
$74K 0.01%
105
– –
IEFA icon
328
iShares Core MSCI EAFE ETF
IEFA
$193B
$73K 0.01%
1,038
– –
BHC icon
329
Bausch Health
BHC
$2.58B
$71.3K ﹤0.01%
8,852
– –
PKG icon
330
Packaging Corp of America
PKG
$22.4B
$71.1K ﹤0.01%
316
+295
+1,405% +$68.2K
SHW icon
331
Sherwin-Williams
SHW
$87.3B
$69K ﹤0.01%
203
– –
MCHP icon
332
Microchip Technology
MCHP
$42.8B
$67.3K ﹤0.01%
1,174
– –
VRTX icon
333
Vertex Pharmaceuticals
VRTX
$121B
$67.3K ﹤0.01%
167
– –
DD icon
334
DuPont de Nemours
DD
$18.6B
$67.1K ﹤0.01%
701
– –
CTVA icon
335
Corteva
CTVA
$50.5B
$67.1K ﹤0.01%
1,178
– –
OKE icon
336
Oneok
OKE
$53.6B
$66.9K ﹤0.01%
666
-74
-10% -$7.57K
KTB icon
337
Kontoor Brands
KTB
$4.77B
$66.7K ﹤0.01%
781
– –
NVO
338
Novo Nordisk
NVO
$210B
$66.7K ﹤0.01%
775
-17
-2% -$1.84K
FVD icon
339
First Trust Value Line Dividend Fund
FVD
$8.29B
$65.5K ﹤0.01%
1,500
– –
JCI icon
340
Johnson Controls International
JCI
$89.9B
$65.4K ﹤0.01%
829
– –
SCHM icon
341
Schwab US Mid-Cap ETF
SCHM
$14.9B
$64.3K ﹤0.01%
2,322
– –
LYB icon
342
LyondellBasell Industries
LYB
$19.2B
$62.8K ﹤0.01%
845
– –
DG icon
343
Dollar General
DG
$28B
$61.6K ﹤0.01%
813
-2,965
-78% -$234K
PLD icon
344
Prologis
PLD
$131B
$61.6K ﹤0.01%
583
-55
-9% -$6.32K
NOBL icon
345
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.7B
$60.9K ﹤0.01%
1,224
– –
DTE icon
346
DTE Energy
DTE
$29.2B
$60.5K ﹤0.01%
501
-7
-1% -$863
PFF icon
347
iShares Preferred and Income Securities ETF
PFF
$13.3B
$57.6K ﹤0.01%
1,833
-293
-14% -$9.57K
VTRS icon
348
Viatris
VTRS
$20.3B
$57.6K ﹤0.01%
4,627
-343
-7% -$4.22K
ROST icon
349
Ross Stores
ROST
$81.1B
$57.3K ﹤0.01%
+379
New +$55.7K
EOG icon
350
EOG Resources
EOG
$76B
$55.4K ﹤0.01%
452
-40
-8% -$5.11K
12 13
14
15 16

Similar funds

SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
BWC
Blue Whale Capital London, United Kingdom $2.1B AUM 97.03% 1-Year Est. Return
CF
Centaurus Financial Anaheim, California $2.1B AUM 21.28% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
IVAV
Index Venture Associates VI St. Helier, Channel Islands, Jersey $2.11B AUM 13.76% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Oakworth Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Oakworth Capital held 694 positions worth $1.45B, up 0.76% from $1.44B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Oakworth Capital's Q4 2024 filing shows 26 new, 100 increased, 172 reduced and 65 closed positions. Its largest new stake was Neurocrine Biosciences: 2,774 shares worth $379K. The largest sale was Regions Financial, an estimated $3.18M.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.7% a quarter earlier, followed by Financials and Industrials.

  • Oakworth Capital's largest Q4 2024 buy was Neurocrine Biosciences: 2,774 shares worth $379K.
  • Oakworth Capital added most to Vanguard Total Bond Market in Q4 2024, an estimated $5.57M increase.
  • Oakworth Capital's biggest Q4 2024 reduction was Regions Financial, cutting an estimated $3.18M.
  • Oakworth Capital fully exited iShares National Muni Bond ETF in Q4 2024, selling an estimated $769K.
  • Oakworth Capital's ten largest holdings make up 62% of its $1.45B portfolio in Q4 2024.
  • Oakworth Capital opened 26 new positions and closed 65 in Q4 2024.
  • Oakworth Capital's portfolio value rose 0.76% quarter-over-quarter to $1.45B.

Based on Oakworth Capital's 13F filing for Q4 2024, filed 27 Jan 2025.